IVY BLOCK
LOE Approachingbentoquatam
NDATOPICALLOTIONPriority Review
Approved
Aug 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 23h ago · AI intelligence enriched 3d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
IVY BLOCK (bentoquatam) is a topical lotion designed to provide a protective barrier against urushiol oil, the active allergen in poison ivy, oak, and sumac. Applied preventatively to skin, it forms a clear coating that binds urushiol and prevents allergic contact dermatitis. This is a small-molecule barrier product rather than a systemic therapeutic.
LOE Approaching
With LOE approaching and a highly competitive market (30% competitive pressure), the brand team is likely in maintenance mode with modest headcount expectations.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Ivy Block offers limited career upside due to LOE approaching and zero linked job openings. This role is best suited for professionals seeking stable, maintenance-level commercial experience rather than launch or growth acceleration.
Brand ManagerField Sales Representative
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.